WUXIBODY
Live / Registered — Registered (as of 21 Dec 2021)
What this means for you
Registered since 21 Dec 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87734294
- Registration number
- 6598098
- Mark type
- Design + words
- Filed
- 26 Dec 2017
- Published for opposition
- 29 May 2018
- Registered
- 21 Dec 2021
- Attorney of record
- Michael T. Smith
Goods and services
- Class 005 — Pharmaceuticals: Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cancer, autoimmune disease, coagulation disorder, infectious disease; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations, namely, therapeutic antibody drug containing a bispecific antibody formulation which can be used to treat cancers, inflammatory diseases, autoimmune diseases, infectious diseases, and coagulation disorders; Biological preparations for the treatment of cancer, autoimmune disease, coagulation disorder, infectious disease; Disinfectants for hygiene purposes; Chewing gum for medical purposes; Nutritional supplements
Owner
- WUXI BIOLOGICS IRELAND LIMITED, DUNDALK, COUNTY LOUTH, IE
- WuXi AppTec Biopharmaceuticals Co., Ltd., Mashan, WuXi,, CN
- WuXi AppTec Biopharmaceuticals Co., Ltd., Mashan, WuXi,, CN
- WuXi AppTec Biopharmaceuticals Co., Ltd., Mashan, WuXi,, CN
Prosecution history
- 01 Jun 2022 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 25 May 2022 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 21 Dec 2021 — REGISTERED-PRINCIPAL REGISTER
- 19 Nov 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 18 Nov 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 18 Nov 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Nov 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 18 Nov 2021 — ASSIGNED TO LIE
- 15 Nov 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 02 Jul 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 02 Jul 2021 — NON-FINAL ACTION E-MAILED
- 02 Jul 2021 — SU - NON-FINAL ACTION - WRITTEN
- 25 Jun 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 21 Jun 2021 — USE AMENDMENT FILED
- 21 Jun 2021 — TEAS STATEMENT OF USE RECEIVED